Shen 2005.
Methods | Randomised double‐blind, multicentre trial |
Participants | Patients with depressive disorder |
Interventions | Fluoxetine: 113 participants Reboxetine: 109 participants Fluoxetine dose: 20 mg/day Reboxetine dose: 8 mg/day |
Outcomes | Hamilton Depression Rating Scale‐17 item (HDRS‐17), Hamilton Rating Scale for Anxiety (HAM‐A), Clinical Global Impression (CGI) |
Notes | Waiting for translation from Chinese to English (only abstract available in English) |